Global Ureteral Access Sheath Market - Key Trends & Drivers Summarized
What's Fueling the Rise in Minimally Invasive Urological Interventions?
The surge in demand for ureteral access sheaths (UAS) is closely tied to the global shift toward minimally invasive urological procedures, particularly for the management of kidney stones and ureteral obstructions. As the incidence of urolithiasis continues to rise - driven by factors such as sedentary lifestyles, high dietary sodium intake, obesity, and dehydration - healthcare systems are increasingly adopting flexible ureteroscopy and other endoscopic techniques to improve patient outcomes. UAS plays a crucial role in these procedures by facilitating repeated access to the upper urinary tract while minimizing trauma to the ureter, reducing intrarenal pressure, and improving visibility for stone extraction or laser lithotripsy. Its ability to enable smooth instrument exchanges without compromising irrigation flow or endoscopic maneuverability has made it indispensable in high-volume urology practices. Furthermore, the reduced need for dilatation and shorter procedure times contribute to decreased operative risks and faster patient recovery. The growing preference for day-care surgeries and ambulatory centers is further accelerating the use of UAS, making it a central tool in the modern urologist's arsenal.How Are Product Innovations Enhancing Performance and Procedural Efficiency?
Technological advancements are significantly elevating the utility and performance of ureteral access sheaths, enabling safer and more efficient endourological procedures. Key developments include the introduction of hydrophilic coatings that reduce friction and improve navigation through the ureter, thereby minimizing mucosal trauma. Modern UAS models are now available in a wide range of diameters and lengths to accommodate varying anatomical and procedural requirements, including pediatric applications. Reinforced sheath designs using kink-resistant polymers offer enhanced durability and flexibility without compromising navigability. Dual-lumen sheaths have also been introduced, allowing for simultaneous irrigation and suction, which improves stone clearance rates and visibility. Additionally, radiopaque markers and enhanced tip designs allow for better fluoroscopic guidance during insertion. Integration with digital ureteroscopes and laser lithotripsy systems is driving compatibility-focused innovation, while single-use, disposable UAS options are gaining traction to reduce infection risks and eliminate reprocessing costs. These technological enhancements are not only improving clinical outcomes but also enhancing procedural economics and patient safety.Why Are Healthcare Ecosystems Worldwide Embracing UAS More Rapidly Than Ever?
The increasing global acceptance of UAS is being bolstered by a confluence of clinical, institutional, and economic drivers. Hospitals and surgical centers are under pressure to reduce complication rates, shorten patient recovery times, and optimize the use of operating rooms - criteria that UAS-equipped procedures help fulfill. As a result, more training institutions and urology residency programs are incorporating UAS-based techniques into their core curricula. Reimbursement frameworks in developed healthcare markets, especially in the U.S. and Europe, now support endoscopic urological interventions, further legitimizing and incentivizing the use of access sheaths. Developing countries, too, are experiencing a surge in UAS adoption thanks to increasing healthcare investments, urbanization, and rising urological awareness among patients. Medical tourism hubs in Asia and the Middle East are upgrading their urology departments with the latest UAS-compatible equipment to cater to international clientele. Meanwhile, collaborations between device manufacturers and surgical training organizations are ensuring wider dissemination of UAS handling skills. As clinical evidence continues to demonstrate improved outcomes and reduced post-operative complications, healthcare systems are increasingly standardizing UAS use across various urological procedures.What Are the Main Drivers Behind the Expanding Ureteral Access Sheath Market?
The growth in the ureteral access sheath market is driven by several factors that stem from clinical practices, technology adoption, and healthcare delivery trends. Rising prevalence of nephrolithiasis and related urological disorders is the foremost demand driver, necessitating higher volumes of ureteroscopic procedures where UAS use is standard. On the technological front, improvements in sheath design, such as low-friction coatings, reinforced shafts, and better compatibility with digital endoscopes, have significantly increased procedural efficiency and surgeon confidence. Increasing preference for outpatient and same-day discharge surgeries is aligning well with the minimally invasive nature of UAS-assisted interventions. Meanwhile, the widespread transition toward single-use medical devices is pushing disposable UAS sales, especially in infection-sensitive settings. Market expansion is also being supported by rising healthcare infrastructure investments in emerging economies and the broader trend of urology service decentralization from hospitals to ambulatory surgical centers. Finally, the growing emphasis on evidence-based medicine and clinical guideline updates that recommend UAS use in complex stone retrieval procedures is ensuring its continued adoption and integration into routine urological care pathways.Report Scope
The report analyzes the Ureteral Access Sheath market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:- Segments: Type (Below 10 Fr, 10 -12 Fr, 13 - 15 Fr); End-Use (Hospitals, Specialty Clinics, Ambulatory Surgery Centers).
- Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Below 10 Fr segment, which is expected to reach US$1 Billion by 2032 with a CAGR of a 3.6%. The 10 -12 Fr segment is also set to grow at 4.4% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $362.5 Million in 2025, and China, forecasted to grow at an impressive 6.9% CAGR to reach $356.3 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Ureteral Access Sheath Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Ureteral Access Sheath Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Ureteral Access Sheath Market expected to evolve by 2032?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2032?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Ace Medical Devices, Amecath, Applied Medical, BD (Becton, Dickinson), Beyomed Medical and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the companies featured in this Ureteral Access Sheath market report include:
- Ace Medical Devices
- Amecath
- Applied Medical
- BD (Becton, Dickinson)
- Beyomed Medical
- Blueneem Medical Devices
- Boston Scientific
- Coloplast
- Cook Medical
- C.R. Bard (BD)
- Envaste Ltd.
- Karl Storz
- Mednova Medical Technology
- Olympus Corporation
- Oscor Inc.
- Princeton Medical Scientific
- Richard Wolf GmbH
- Rocamed
- Terumo Corporation
- Well Lead Medical
What Sets This Report Apart From Others?
- Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
- Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
- Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
- Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
- Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
- Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, our reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Ace Medical Devices
- Amecath
- Applied Medical
- BD (Becton, Dickinson)
- Beyomed Medical
- Blueneem Medical Devices
- Boston Scientific
- Coloplast
- Cook Medical
- C.R. Bard (BD)
- Envaste Ltd.
- Karl Storz
- Mednova Medical Technology
- Olympus Corporation
- Oscor Inc.
- Princeton Medical Scientific
- Richard Wolf GmbH
- Rocamed
- Terumo Corporation
- Well Lead Medical
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 280 |
| Published | November 2026 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 1.3 Billion |
| Forecasted Market Value ( USD | $ 1.8 Billion |
| Compound Annual Growth Rate | 4.0% |
| Regions Covered | Global |


